Pharmacological inhibition on the ataxia telangiectasia and Rad3-relevant protein serine/threonine kinase (ATR; generally known as FRAP-linked protein (FRP1)) has emerged as being a promising strategy for cancer therapy that exploits artificial lethal interactions with proteins linked to DNA injury repair service, overcomes resistance to other therapies and boosts antitumour immunity. https://jh-x-119-0145511.jiliblog.com/84225774/tabilautide-secrets